Msn Laboratories Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is CLIDINIUM BROMIDE USP, with a corresponding US DMF Number 32674.
Remarkably, this DMF maintains an Active status since its submission on March 30, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 09, 2019, and payment made on June 21, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II